News

ESSA Pharma Inc. announced that it has entered into a definitive agreement with Realm Therapeutics plc setting forth the terms of an acquisition whereby ESSA will acquire all of the…
Read More...

Intec Pharma Ltd. announces it has entered into an agreement with Merck, known as MSD outside the United States and Canada, to explore using the Accordion Pill® (AP) platform for an…
Read More...

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced a collaboration to launch Phathom Pharmaceuticals, a biopharmaceutical company focused on the development…
Read More...

RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repair and regeneration, reported that its U.S. joint venture partner and Pan Asian…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax) in combination with Gazyva (obinutuzumab) for the treatment of people with previously…
Read More...

Cumberland Pharmaceuticals Inc. announced it has entered into an exclusive agreement with China's Winhealth Pharma Group for the licensing rights of Acetadote (acetylcysteine)…
Read More...

Vertex Pharmaceuticals Incorporated and Kymera Therapeutics announced that the two companies have entered into a four-year strategic research and development collaboration to advance…
Read More...

Codexis, Inc. announces the signing of a CodeEvolver platform agreement with Novartis. Under the terms of the agreement, Codexis has granted a non-exclusive license to its proprietary…
Read More...

ProBioGen AG, a premier German service & technology provider for complex biologics and Vaccitech, Ltd., a spin-out company from the University of Oxford’s Jenner Institute, one of…
Read More...

Adaptimmune Therapeutics and Alpine Immune Sciences announced a collaboration and license agreement to develop next-generation SPEAR T-cell products which incorporate Alpine’s secreted…
Read More...

Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization (CDMO) specializing in pharmaceuticals and medical devices, announced that…
Read More...

TraceLink Inc. announced the acceptance of its participation in the Food and Drug Administration (FDA) Pilot Project Program under the Drug Supply Chain Security Act (DSCSA).…
Read More...

Chiasma, Inc. and Lonza announced that the companies have entered into a commercial supply agreement for Chiasma’s oral somatostatin analog candidate, conditionally trade named…
Read More...

Zymeworks Inc. announced that it has entered into a licensing agreement that grants Iconic Therapeutics, Inc. (Iconic) non-exclusive rights to Zymeworks’ proprietary ZymeLink…
Read More...

Hoth Therapeutics, announced that the company has signed a term sheet with Zylö Therapeutics Inc (Zylö) to co-develop a new treatment for patients suffering from Cutaneous Lupus…
Read More...

AbbVie announced that it has resolved U.S. HUMIRA (adalimumab) litigation with Boehringer Ingelheim (BI). Under the terms of the resolution, AbbVie will grant BI a non-exclusive license…
Read More...

Exelixis, Inc. announced its partner Daiichi Sankyo Company, Limited has launched MINNEBRO (esaxerenone) tablets as a treatment for patients with hypertension in Japan. With Daiichi…
Read More...

ElevateBio announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and…
Read More...

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to POMALYST (pomalidomide) for the treatment of patients with…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from…
Read More...